SIRT1 expression is associated with poor prognosis of lung adenocarcinoma

References

• LandryJSuttonATafrovSTThe silencing protein SIR2 and its homologs are NAD-dependent protein deacetylasesProc Natl Acad Sci U S A200097115807581110811920
   PubMed Web of Science ®Google Scholar
• Voelter-MahlknechtSMahlknechtUCloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1Int J Mol Med2006171596716328012
   PubMed Web of Science ®Google Scholar
• LuoJNikolaevAYImaiSNegative control of p53 by Sir2alpha promotes cell survival under stressCell2001107213714811672522
   PubMed Web of Science ®Google Scholar
• PediconiNGuerrieriFVossioShSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damageMol Cell Biol20092981989199819188449
   PubMed Web of Science ®Google Scholar
• FuMLiuMSauveAAHormonal control of androgen receptor function through SIRT1Mol Cell Biol200626218122813516923962
   PubMed Web of Science ®Google Scholar
• YeungFHobergJERamseyCSModulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylaseEMBO J200423122369238015152190
   PubMed Web of Science ®Google Scholar
• BrunetASweeneyLBSturgillJFStress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylaseScience200430356662011201514976264
   PubMed Web of Science ®Google Scholar
• DerrRSvan HoeselAQBenardAHigh nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patientsBMC Cancer20141460425139823
   PubMed Web of Science ®Google Scholar
• HanLLiangXHChenLXBaoSMYanZQSIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migrationInt J Clin Exp Pathol20136112357236524228097
   PubMed Web of Science ®Google Scholar
• ChenWBhatiaRRoles of SIRT1 in leukemogenesisCurr Opin Hematol201320430831323519155
   PubMed Web of Science ®Google Scholar
• HuffmanDMGrizzleWEBammanMMSIRT1 is significantly elevated in mouse and human prostate cancerCancer Res200767146612661817638871
   PubMed Web of Science ®Google Scholar
• LangleyEPearsonMFarettaMHuman SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescenceEMBO J200221102383239612006491
   PubMed Web of Science ®Google Scholar
• WangRHZhengYKimHSInterplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesisMol Cell2008321112018851829
   PubMed Web of Science ®Google Scholar
• ChenHCJengYMYuanRHHsuHCChenYLSIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosisAnn Surg Oncol20121962011201922146883
   PubMed Web of Science ®Google Scholar
• JangKYHwangSHKwonKSSIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphomaAm J Surg Pathol200832101523153118724249
   PubMed Web of Science ®Google Scholar
• ChaEJNohSJKwonKSExpression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinomaClin Cancer Res200915134453445919509139
   PubMed Web of Science ®Google Scholar
• NoguchiAKikuchiKZhengHSIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancerCancer Med2014361553156125146318
   PubMed Web of Science ®Google Scholar
• LeeHKimKRNohSJExpression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinomaHum Pathol201142220421321056897
   PubMed Web of Science ®Google Scholar
• WuMWeiWXiaoXExpression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancerMed Oncol20122953240324922661383
   PubMed Web of Science ®Google Scholar
• KimJRMoonYJKwonKSExpression of SIRT1 and DBC1 is associated with poor prognosis of soft tissue sarcomasPLoS One201389e7473824019980
   PubMed Web of Science ®Google Scholar
• ChenXSunKJiaoSHigh levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patientsSci Rep20144748125500546
   PubMed Web of Science ®Google Scholar
• JungWHongKDJungWYSIRT1 expression is associated with good prognosis in colorectal cancerKorean J Pathol201347433233924009628
   PubMedGoogle Scholar
• NoguchiALiXKubotaASIRT1 expression is associated with good prognosis for head and neck squamous cell carcinoma patientsOral Surg Oral Med Oral Pathol Oral Radiol2013115338539223453030
   PubMed Web of Science ®Google Scholar
• ChenPZhuJLiuDYLiHYXuNHouMOver-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosisMed Oncol201431177524338338
   PubMed Web of Science ®Google Scholar
• ZhangTRongNChenJSIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLCPLoS One2013811e7916224223900
   PubMed Web of Science ®Google Scholar
• NohSJBaekHAParkHSExpression of SIRT1 and cortactin is associated with progression of non-small cell lung cancerPathol Res Pract2013209636537023702379
   PubMed Web of Science ®Google Scholar
• ChenXHokkaDManiwaYOhbayashiCItohTHayashiYSirt1 is a tumor promoter in lung adenocarcinomaOncol Lett20148138739324959282
   PubMed Web of Science ®Google Scholar
• AltieriDCSurvivin, cancer networks and pathway-directed drug discoveryNat Rev Cancer200881617018075512
   PubMed Web of Science ®Google Scholar
• WangMLiuBGYangZYHongXChenGYSignificance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancerExp Ther Med20123698398822970003
   PubMed Web of Science ®Google Scholar
• KanwarJRKamalapuramSKKanwarRKTargeting survivin in cancer: the cell-signalling perspectiveDrug Discov Today20111611–1248549421511051
   PubMed Web of Science ®Google Scholar
• TangXPLiJYuLCClinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgeryLung Cancer201381227327923756092
   PubMed Web of Science ®Google Scholar
• SunPLJinYKimHSurvivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinomaVirchows Arch2013463342743623907568
   PubMed Web of Science ®Google Scholar
• ZhangLQWangJJiangFXuLLiuFYYinRPrognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysisPLoS One201273e3410022457815
   PubMed Web of Science ®Google Scholar
• SuzukiKHayashiRIchikawaTSRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in miceOncol Rep20122761726173222470132
   PubMed Web of Science ®Google Scholar